Genetic Technologies Ltd

(GENE) Trade

By |

Profile

Genetic Technologies Ltd is an Australia-based molecular diagnostics company which offers predictive testing and assessment tools to help physicians proactively manage women's health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breast cancer. It also provides genetic testing services including medical testing, animal testing, forensic testing, and plant testing. The company markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/ gynecologists (OBGYNs) and breast cancer risk assessment specialists. The majority of the company's revenue is generated from Australia and the United States.

Contact Information

Website: www.gtglabs.com
Main Phone: +61 384127000
Address: 60-66 Hanover Street
Address 2: P.O. Box 115
State: VIC
City / Town: Fitzroy
Country: AUS
Postal Code: 3065

Issuer Information

Exchange: NSC
CEO: Jerzy Muchnicki
Employees: 16
NAICS: Biological Produ

Equities News

Profile

Genetic Technologies Ltd is an Australia-based molecular diagnostics company which offers predictive testing and assessment tools to help physicians proactively manage women's health. The company has developed BREVAGenplus which is a clinically validated risk assessment test for non-hereditary breast cancer. It also provides genetic testing services including medical testing, animal testing, forensic testing, and plant testing. The company markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/ gynecologists (OBGYNs) and breast cancer risk assessment specialists. The majority of the company's revenue is generated from Australia and the United States.

Contact Information

Website: www.gtglabs.com
Main Phone: +61 384127000
Address: 60-66 Hanover Street
Address 2: P.O. Box 115
State: VIC
City / Town: Fitzroy
Country: AUS
Postal Code: 3065

Issuer Information

Exchange: NSC
CEO: Jerzy Muchnicki
Employees: 16
NAICS: Biological Produ

Equities News

$ 1.79 $ -0.01 (-0.56%)
Last Price 1.79 Change $ -0.01 Change % -0.56 Tick N/A
Bid 1.60 Bid Size 2,000.00 Ask 2.08 Ask Size 1,000.00
Open 1.80 High 1.82 Low 1.76 Prev Close 1.80
Last Trade Volume 7,031 52 Wk Hi 6.32 52 Wk Low 1.56
Market Cap 9.4 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 5,246,670.00 EPS (TTM) -0.21 PE Ratio N/A Exchange NCM
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 2.5 2.5 2.5 2.5
Low Target Price Estimate 2.5 2.5 2.5 2.5
Mean Target Price Estimate 2.5 2.5 2.5 2.5
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 09/02/14 09/02/14 09/02/14 09/02/14
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 0 0 0 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 3